The National Institutes of Health awarded nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19. The NIH Researching COVID to Enhance Recovery (RECOVER) Initiative made the parent award to New York University (NYU) Langone Health, New York City,...
Researchers identified genes and pathways involved in triggering a hyperinflammatory COVID-19 immune response – starting with platelets – and are studying how inhibiting these pathways may alter clinical outcomes for hospitalized patients.
A phase 2 study with 59 patients found fostamatinib, a targeted immune therapy used for a rare bleeding disorder, did not result in more adverse outcomes among adults hospitalized for COVID-19 who required assisted breathing support.
After following more than 123,000 women, ages 50-79, for 15 years, researchers found that those who ate a higher proportion of plant-based foods with healthful fats had a reduced risk for cardiovascular disease, coronary heart disease, and heart failure.